MK0952 in Patients With Mild-to-Moderate Alzheimer's Disease (0952-004)(COMPLETED)
Alzheimer's Disease
About this trial
This is an interventional treatment trial for Alzheimer's Disease
Eligibility Criteria
Inclusion Criteria: Male or females Age >/= 55 years, With mild-to-moderate AD, with MMSE between 18 and 26, inclusive, MHIS score </= 4, Global CDR score of 1 or 2 Who have a reliable informant/caregiver to accompany patient to all clinic visits If using a symptomatic AD treatments, patients must be on stable dose for >/= 6 months Exclusion Criteria: Patients must not be living in nursing home or skilled nursing facility Patients must not have current evidence and/or history of Crohn's disease, ulcerative colitis, proctitis, GI bleeding, mesenteric arteritis Patients must not have current evidence and/or history of poorly-controlled hypertension, clinically significant cardiac arrhythmia, angina, or CHF Patients must not have current evidence and/or history of a psychotic disorder or major untreated depressive disorder Patients must not have current evidence and/or history of stroke or multiple lacunar infarcts, or neurological or neurodegenerative disorder (other than AD) Various concomitant therapy restrictions